BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Factor Xia

Below is an extended Factor Xia patents listing. Click here to return to the Factor Xia main in depth entry.

Patents :

US Patent No.Title
7169795 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
7264922 Method of reducing complement - mediated disruption of cells
7265121 Chemical compounds
7270976 Methods for measuring ADAMTS13 activity and protein on platelets and in plasma
7273722 Neurotoxins with enhanced target specificity
7276480 Prevention and reduction of blood loss
7285631 Human cDNAs and proteins and uses thereof
7294627 Chemical compounds
7297706 Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders
7300922 Modulators of pharmacological agents
7304041 Modulators of coagulation factors
7259234 Stable analogs of peptide and polypeptide therapeutics
7252799 Methods for sterilizing preparations containing albumin
7250415 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, .beta.-aminoacids, .alpha.-aminoacids and derivatives thereof as factor Xa inhibitors
7183391 Kunitz domain polypeptide zkun10
7199149 Monocyclic and bicyclic lactams as factor Xa inhibitors
7205318 Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
7208601 Aryl and heteroaryl compounds, compositions, and methods of use
7211671 Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE)
7214479 E. coli O157:H7 C1-INH-binding protein and methods of use
7217794 Compounds and methods for treatment of thrombosis
7220569 Nucleic acids encoding factor X analogues having a modified protease cleavage site
7235530 Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
7247654 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors
7312214 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors
7312218 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
7388021 Urea antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic conditions
7392140 Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
7405280 Chromogenic substances and use thereof for the determination of carboxypeptidase activities
7417063 Bicyclic heterocycles useful as serine protease inhibitors
7419948 Treatment of hemophilia with human Factor IX produced in mammary tissue of transgenic mammals
7425328 Tissue factor antibodies and uses thereof
7425539 Factor IXa for the treatment of bleeding disorders
7427490 Diagnostic markers of stroke and cerebral injury and methods of use thereof
7427632 Factor Xa inhibitors
7429566 Method for treating Hemophilia B
7381732 Pyrazolobenzamides and derivatives as factor Xa inhibitors
7378393 Recombinant anticoagulant proteins
7371761 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
7312325 RNA aptamers and methods for identifying the same
7329640 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
7329725 Phage displayed Trp cage ligands
7338963 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
7354585 Methods of treating coagulapathic or thrombotic disorders
7355015 Matriptase, a serine protease and its applications
7358055 Diagnostic markers of acute coronary syndrome and methods of use thereof
7361473 Diagnostic markers of acute coronary syndrome and methods of use thereof
7371722 Pharmaceutical preparations and medicine capable of generating and/or containing thrombin
7371743 Carboxylic acid amides, the preparation thereof and their use as medicaments
7429604 Six-membered heterocycles useful as serine protease inhibitors
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional